IL17A and experimental autoimmune encephalomyelitis: Knockout ACT1 (a key transcription factor for signals mediated by IL-17A, IL-17F, and IL-17C) reduced the number of infiltrating inflammatory cells and ameliorates experimental autoimmune encephalomyelitis [112].